Long-term follow-up of cerebral infarction patients with proton magnetic resonance spectroscopy.
Author(s) -
Peter Gideon,
B Sperling,
P Arlien-Søborg,
Tom Skyhøj Olsen,
O. Henriksen
Publication year - 1994
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/01.str.25.5.967
Subject(s) - medicine , cerebral blood flow , creatine , magnetic resonance imaging , stage (stratigraphy) , blood flow , choline , stroke (engine) , infarction , cerebral infarction , lesion , nuclear medicine , pathology , ischemia , cardiology , radiology , myocardial infarction , mechanical engineering , paleontology , engineering , biology
With proton magnetic resonance spectroscopy it is possible to measure the content of various brain metabolites in vivo, including N-acetylaspartate (which may be used as a neuronal marker), creatine, choline, and lactate. The content of these brain metabolites was measured serially from the acute stage to the chronic stage of infarction. Regional cerebral blood flow was also measured within the affected areas. These factors were compared with the clinical outcome.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom